Skip to content
L049L049L049

Drawing based on the label description. No photo yet.

“Clarithromycin is available as: Clarithromycin extended-release tablets USP 500 mg are supplied as yellow, modified capsule shaped, biconvex, film coated tablets, imprinted with "L049" in black ink on one side and plain on other side”

L049 pill

Pill with imprint L049 is yellow, capsule, 20 mm and has been identified as Clarithromycin 500 mg. It is used for ulcers, H. pylori infection and bronchitis. It is supplied by Lupin Pharmaceuticals, Inc.

Clarithromycin 500 mg

Imprint
L049
Strength
500 mg
Used for
Ulcers, H. pylori infection and bronchitis
Color
Yellow
Shape
Capsule / oblong
Size
20 mm
Score
No score line
Form
Tablet, extended release
Manufacturer
Lupin Pharmaceuticals, Inc
Drug class
Antibiotic (macrolide)
NDC
68180-177, 68180-177-07

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Clarithromycin pills and guides

What is Clarithromycin used for?

Clarithromycin is used for ulcers, H. pylori infection, bronchitis and sinus infections.

Medicine type
Antibiotic (macrolide)
Official uses from the US prescribing label

Acute Bacterial Exacerbation of Chronic Bronchitis

Clarithromycin tablets are indicated in adults for the treatment of mild to moderate infections caused by susceptible isolates due to Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, or Streptococcus pneumoniae.

Acute Maxillary Sinusitis

Clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae.

Community-Acquired Pneumonia

Clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to:

  • Haemophilus influenzae(in adults)
  • Mycoplasma pneumoniae, Streptococcus pneumoniae, Chlamydophila pneumoniae(clarithromycin tablets [in adults and pediatric patients])

Pharyngitis/Tonsillitis

Clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to Streptococcus pyogenesas an alternative in individuals who cannot use first line therapy.

Uncomplicated Skin and Skin Structure Infections

Clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to Staphylococcus aureus, or Streptococcus pyogenes.

Acute Otitis Media

Clarithromycin tablets are indicated in pediatric patients for the treatment of mild to moderate infections caused by susceptible isolates due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae.

Treatment and Prophylaxis of Disseminated Mycobacterial Infections

Clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to Mycobacterium aviumor Mycobacterium intracellularein patients with advanced HIV infection.

Helicobacter pylori Infection and Duodenal Ulcer Disease

Clarithromycin tablets are given in combination with other drugs in adults as described below to eradicate H. pylori. The eradication of H. pylorihas been demonstrated to reduce the risk of duodenal ulcer recurrence.

  • Clarithromycin tablets in combination with amoxicillin and PREVACID (lansoprazole) or PRILOSEC (omeprazole) Delayed-Release Capsules, as triple therapy, are indicated for the treatment of patients with H. pyloriinfection and duodenal ulcer disease (active or five-year history of duodenal ulcer) to eradicate H. pylori.
  • Clarithromycin tablets in combination with PRILOSEC (omeprazole) capsules are indicated for the treatment of patients with an active duodenal ulcer associated with H. pyloriinfection. Regimens which contain clarithromycin tablets as the single antibacterial agent are more likely to be associated with the development of clarithromycin resistance among patients who fail therapy. Clarithromycin-containing regimens should not be used in patients with known or suspected clarithromycin resistant isolates because the efficacy of treatment is reduced in this setting.

Limitations of Use

There is resistance to macrolides in certain bacterial infections caused by Streptococcus pneumoniaeand Staphylococcus aureus. Susceptibility testing should be performed when clinically indicated.

Usage

To reduce the development of drug-resistant bacteria and maintain the effectiveness of clarithromycin tablets and other antibacterial drugs, clarithromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

From the FDA-approved label on DailyMed (published Sep 18, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows L049 and the other side is plain.
  • It is yellow, capsule, 20 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Clarithromycin

Inactive: D&c Yellow No. 10, Hypromelloses, Povidone K30, Shellac, Hydroxypropyl Cellulose (1600000 Wamw), Lactose Monohydrate, Magnesium Stearate, Propylene Glycol, Titanium Dioxide, Ferrosoferric Oxide, Silicon Dioxide

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Clarithromycin pills